pirtobrutinib
Pirtobrutinib is a drug used to treat Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Mantle-Cell, and other conditions. Pirtobrutinib is being actively studied in 8 studies; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Loxo Oncology, Inc. | Memorial Sloan Kettering Cancer Center | |
| Eli Lilly and Company | Nagoya Medical Center | |
| M.D. Anderson Cancer Center | Florida Cancer Specialists |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
L
Active, not recruiting
- Healthy
- Rosuvastatin
- Pirtobrutinib
- Springfield, Missouri
- +1 more
2022-03-22
Mar 22, 2022M
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- Venetoclax
- Houston, TexasM D Anderson Cancer Center
2022-04-07
Apr 7, 2022L
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- Pirtobrutinib
- Ibrutinib
- (no location specified)
2022-02-15
Feb 15, 2022L
Available
- Leukemia, Lymphocytic, Chronic, B-Cell
- +4 more
- Pirtobrutinib
- Stanford, California
- +19 more
2022-04-05
Apr 5, 2022L
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
- Fort Myers, Florida
- +26 more
2021-11-16
Nov 16, 2021L
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
- Los Angeles, California
- +40 more
2022-03-11
Mar 11, 2022E
Recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
- LOXO-338
- Pirtobrutinib
- Miami, Florida
- +4 more
2022-03-07
Mar 7, 2022L
Recruiting
- Chronic Lymphocytic Leukemia
- +5 more
- Pirtobrutinib
- +2 more
- Scottsdale, Arizona
- +55 more
2022-01-12
Jan 12, 2022L
Recruiting
- Lymphoma, Mantle-Cell
- Pirtobrutinib
- +3 more
- Phoenix, Arizona
- +147 more
2022-03-04
Mar 4, 2022